Sanofi Diabetes
One card. Up to 12 LANTUS® SoloSTAR® pen prescriptions. Pay No More Than $25. Certain restrictions apply. Start saving & enroll now >>

Prescription Lantus® (insulin glargine [rDNA origin] injection) is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Lantus® to treat diabetic ketoacidosis.

Important Safety Information for Lantus® (insulin glargine [rDNA origin] injection)

Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients in Lantus®.

Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

You must test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible.

Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Lantus®, tell your doctor about all your medical conditions including if you have heart failure or other heart problems, liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed. If you have heart failure, it may get worse while you take TZDs with Lantus®.

The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include swelling, weight gain, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening.

Lantus® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Lantus®.

Click here for information on Sharps Medical Waste Disposal.

Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.

SEND
Sign Up Now.
Pay no more than $25 on up to six prescriptions*

*Certain eligibility restrictions apply. See Savings Card for details when you enroll.

Register Today

Please fill out the following information. The information you provide below will be used to sign you up for the Lantus® periodic emails and send you additional communications about Lantus®, insulin, diabetes, related conditions and products.

By providing information in the enrollment form below, you are providing your consent to participate in the Sanofi US Diabetes Education and Support Program (the “Program”).

Sanofi US respects your interest in keeping your personal information private. Sanofi US will not sell or rent your information to any unauthorized parties or mailing lists. The information you provide will only be used by Sanofi US, its affiliates or contracted service providers (“Sanofi”), to provide you with information and materials made available as part of the Program. This information may include information about diabetes, insulin, related products and health conditions, as well as opportunities to participate in market research performed on behalf of Sanofi. In addition, your information may be used by Sanofi to identify ways to optimize the services provided as part of the Program.

By participating in the Program, you also consent to be contacted by mail, email, phone calls, voice messages, SMS text messages and interactive voice recordings.

You may unsubscribe from the Program at any time by visiting https://unsubscribe.sanofi-aventis.us or by calling 1-800-633-1610.


*Fields marked with asterisks are required.















   






  • I am over 18 and enrolling for myself
  • I am a parent or caregiver enrolling for my child.

  • Type 1
  • Type 2
  • Don't Know
  • Parent or Caregiver of Child with Type 1
  • Other

Tell Us About Your Medications





  • Less than 3 years
  • 3 to less than 7 years
  • 7 or more years




  • 0-3 months
  • 3-6 months
  • 6-12 months
  • 12+ months









1Humalog® is a registered trademark of Eli Lilly and Company
2Levemir®, NovoLog®, and Victoza® are registered trademarks of Novo Nordisk A/S.
3Byetta® and Bydureon® are registered trademarks of the AstraZeneca group of companies.
4Tanzeum® is a registered trademark of GlaxoSmithKline.

Save On Lantus®

You've indicated that you are currently taking Lantus®.

Sign up for the Lantus® Savings Card now, and you'll pay no more than $25* per Lantus® SoloSTAR® prescription for the program duration.

Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Lantus® to treat diabetic ketoacidosis.

Important Safety Information for Lantus® (insulin glargine [rDNA origin] injection)

Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients in Lantus®.

Please click here for additional Important Safety Information.

Please click here for Full Prescribing Information.

Important Safety Information for
Lantus® (insulin glargine [rDNA origin] injection)

Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients in Lantus®.

Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

You must test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible.

Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Lantus®, tell your doctor about all your medical conditions including if you have heart failure or other heart problems, liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed. If you have heart failure, it may get worse while you take TZDs with Lantus®.

The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include swelling, weight gain, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening.

Lantus® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Lantus®.
Click here for information on Sharps Medical Waste Disposal.
Click here to learn more about Sanofi's commitment to fighting counterfeit drugs.

Indications and Usage for Apidra® (insulin glulisine [rDNA origin] injection)


Prescription Apidra® is for adults with type 2 diabetes or adults and children (4 years and older) with type 1 diabetes to improve blood sugar control. Apidra® given by subcutaneous injection is usually used with a longer-acting insulin. When used as a mealtime insulin, Apidra® should be given within 15 minutes before or within 20 minutes after starting a meal.

Important Safety Information for Apidra® (insulin glulisine [rDNA origin] injection)


Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are allergic to any of the ingredients in Apidra®.

Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

You must test your blood sugar levels while using insulin, such as Apidra®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. Apidra® must only be used if the solution is clear and colorless with no particles visible.

Apidra®, when given by injection under the skin, should not be mixed with insulins other than NPH. Do not mix Apidra® with any insulin when used in the pump or for intravenous administration.

The most common side effect of insulin, including Apidra®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include low blood potassium, injection site reactions, such as changes in fat tissue at the injection site, and allergic reactions, such as itching and rash. Less common, but potentially more serious or life-threatening, is generalized allergy to insulin, including anaphylactic reactions.

Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Apidra®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or are planning to breast-feed. If you have heart failure or other heart problems, it may get worse while you take TZDs with Apidra®.

Click here for Full Prescribing Information for Apidra®.

Indications and Usage for Toujeo® (insuline glargine injection) U-300

Prescription Toujeo® is a long-acting insulin used to treat adults with type 2 and type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Toujeo® to treat diabetic ketoacidosis.

Important Safety Information for Toujeo® (insuline glargine injection) U-300


Do not take Toujeo® during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Toujeo®.

Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

You must test your blood sugar levels daily while using any insulin, including Toujeo®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Toujeo contains 300 units per milliliter (300 U/mL). You should always verify that you have the correct insulin before each injection. Your dose for Toujeo® may be different from other insulins you have taken. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Toujeo® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Toujeo® must only be used if the solution is clear and colorless with no particles visible.

Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Toujeo®, tell your doctor about all your medical conditions, including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed. If you have heart failure, it may get worse while taking TZDs with Toujeo®.

The most common side effect of any insulin, including Toujeo®, is low blood sugar (hypoglycemia), which may be serious and can be life-threatening. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat and blurred vision. Severe hypoglycemia may cause harm to your heart or brain. Other possible side effects may include swelling, weight gain and allergic reactions. In rare cases, some allergic reactions may be life-threatening. Injection site reactions are also possible and may include changes in fat tissue at the injection site, skin thickening, redness, swelling and itching.

Toujeo® SoloStar® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Toujeo®.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
Blood Sugar Control
Blood Sugar Control Get the Resources That Can Help You Improve It

Get Started Now